DuPont Posts 5% Organic Sales Growth in Third Quarter
DD sits 40% above its 52-week low of $100.005.
Summary
DuPont delivered 5% organic sales growth in the third quarter, a headline number that lands ahead of the company's recent pattern of beats and raised guidance. The quarter brought sales of $1.9B, net income of $123M, EPS of 91c and adjusted EPS of $2.09, with transaction-adjusted free cash flow of $341M. Within the business, Healthcare & Water Technologies sales rose 4% to $865M. The print follows a Q2 in which DuPont topped estimates, lifted its full-year outlook, and authorized a $250 million buyback, so the bar was already high. Organic growth of this size suggests the core business is still expanding despite the portfolio reshaping and the $455 million North Carolina PFAS settlement spread over 15 years that the company, Chemours, and Corteva agreed to in September.
At the time of this announcement, DD was trading at $140.00 on NYSE in the Manufacturing sector, with a market capitalization of approximately $19.1B. The 52-week trading range was $100.01 to $157.98. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.